Market Tracker

06/24 5:16pm ET

Biogen Inc (NASDAQ:BIIB)

229.02
Delayed Data
As of Jun 24
 -9.60 / -4.02%
Today’s Change
229.00
Today|||52-Week Range
417.68
-25.24%
Year-to-Date
Think of This Stock as Buy-ogen
Jun 25 / TheStreet.com - Paid Partner Content
Why Biogen Inc. Is Down 22.5% In 2016
Jun 21 / MotleyFool.com - Paid Partner Content
2 Biotech Stocks That Won't Pay a Dividend Anytime Soon, and 1 That Should
Jun 24 / MotleyFool.com - Paid Partner Content
These 5 Biotech Stocks Are Ridiculously Cheap
Jun 21 / MotleyFool.com - Paid Partner Content
RBC sees biopharma 'insulated' from Brexit, says buy Celgene for bounceback
Jun 24 / TheStreet.com - Paid Partner Content
Stock Market News for June 16, 2016
Jun 16 / Zacks.com - Paid Partner Content
Better Buy: Biogen Inc. vs. Celgene Corporation
Jun 23 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology, Biogen, Alexion Phar...
Jun 13 / Zacks.com - Paid Partner Content
Cramer: Why Can't We Get Together on Mergers?
Jun 22 / TheStreet.com - Paid Partner Content
Is Biogen a Buy After its Clinical Failure?
Jun 12 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close238.62
Today’s open232.00
Day’s range229.00 - 235.30
Volume2,685,048
Average volume (3 months)1,771,302
Market cap$50.2B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+11.01%
Earnings growth (next 5 years)+9.50%
Revenue growth (last year)-3.87%
P/E ratio14.1
Price/Sales7.60
Price/Book5.34

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...-2.11-4.59%
JUNOJuno Therapeutics In...-3.25-7.44%
CTLTCatalent Inc-0.87-3.68%
XONIntrexon Corp-1.20-4.76%
Data as of 4:02pm ET, 06/24/2016

Financials

Next reporting dateJuly 19, 2016
EPS forecast (this quarter)$4.68
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Scientific Officer &
Executive VP
Spyridon Artavanis-Tsakonas
Corporate headquarters
Cambridge, Massachusetts

Forecasts